In another research, Liu et al. have demonstrated increased expression of IL-17A, IL-17RA, IL-17E, and IL-17F in the prostate gland both in BPH and in PCa compared to the expression in the control group. This evidence concerns the gene IL17A and benign prostatic hyperplasia.